Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.73

+0.50 (0.82%)

as of Aug 14, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 14, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has shown a solid performance in recent quarters, buoyed by its strong presence in Asia and effective wealth management strategies. However, there are concerns regarding its valuation, as it is perceived to be somewhat overbought, trading over 2x book value with limited earnings growth expected in the near future. Despite these concerns, many experts highlight its decent dividend yield and ongoing growth potential, particularly in its Asian markets. The recent implementation of a tax on MFC products for mainland Chinese residents adds a layer of uncertainty. Overall, the sentiment among analysts is cautiously optimistic, with a call for careful monitoring of market conditions and potential entry points for investment.

Consensus

Cautious

Valuation

Fair Value

Similar

GWO

SELL

Unimpressive earnings in the last quarter with a loss of $.12. Doesn't feel comfortable with the stock at this point. Doesn't see growth in the near-term. Sold his holdings.

BUY

The hits just keep coming. First they cut the dividend and then issued a massive share issue, which was dilutive. Thinks the worst is behind it. Has been oversold.

BUY

Thinks they are over the hump. Could own SLF or MFC depending on the value at that moment.

TOP PICK

Was startled when they cut the dividend. There were two issues – few ink stains on blotter from prior management and had to decide whether to issue equity now or sit back and get shareholder’s rather if market when down.

STRONG BUY

Did an equity issue that investors felt uncomfortable with but he thinks it was the right thing to do. This increased capital so they can make good acquisitions. Have one of the best franchises in Canada as well as a global franchise. Great growth prospects.

DON'T BUY

Going through a digestion period. They cut the dividend and issued new shares to raise a lot of money, which cheesed a lot of people off. Negative sentiment will take some time to wear off.

COMMENT

Have guided that normalized earnings would be $1.85 per share making it under 10X earnings for the next year. You have to be patient. Expecting a cloud will continue to hang over the stock for a while.

COMMENT

Didn't like the issue of 2.5 billion of new shares. Overly conservative in raising money and diluting existing shareholders. Great exposure to Asia, which is the main thing that differentiates it from their peers. Given the earnings outlook it's a great buy but will be in the penalty box until they start spending some of that money.

WAIT

On a current basis, it is kind of absolute dog. It will remedy itself. At the current time, Sun Life (SLF-T) is better with a 5% dividend versus 3.5% and a market cap that is 2/3 better shape. It might be nearing the bottom that way for a while.

WEAK BUY

It is the premier North American life insurance company. One of the attractions is the operation in the far east. They could benefit from distressed asset purchases. Variable annuity product makes them a leveraged play on the US market. If there is another big correction in the market, they are still very vulnerable.

TOP PICK

Sold half his position when they cut the dividend but at $18 it is trading under 10 X earnings. Great long-term business. Will probably make Asian acquisitions.

HOLD

Feels the worst is over for them but wouldn't add to a position. Trading close to BV. In the penalty box for a while.

BUY

Below $19 there is only upside to the name. SLF would be his pick.

TOP PICK

Stumbled on raising capital and what they had in their guaranteed products. Lots of capital and will make acquisitions. Better growth in lifecos than in banks going forward. Potential to earn $2.50-$3 a share 2 years out, which would put the stock into the mid-$30's.

HOLD

Cut the dividend and then followed up by issuing more shares creating a great deal of dilution. Management is trying to create a bulletproof balance sheet. Doesn't think they have entirely lost the potential upside in an improving market. 2.8% yield.

Showing 1,546 to 1,560 of 2,284 entries

Most Recent Experts

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Richard Orrell

RN Croft Financial Group

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)